Recent News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CSL at All-Time Highs: $320 Fair Value or Defensive Premium?
CSL (ASX:CSL) is trading near record highs around $290. With plasma recovery complete and Vifor integration ahead of schedule, is CSL’s 35x valuation justified—or are investors paying a defensive premium?
Blue Chip Stocks
Growth Stocks
ASX Tech Down 8%: WiseTech, Xero, NextDC—Buy the Dip or Avoid the Trap?
The ASX technology sector has fallen 8%, with WiseTech, Xero, and NextDC facing their first major pullback in over a year. Is this a buying opportunity for long-term investors—or the start of a deeper correction?
No items found.
No items found.
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
Mon - Fri, 8.30am – 5.30pm
Call Us on 1300 720 292
invest@australianstockreport.com.au
Insights
Australian Stock Report is part of the AAIG family of Companies
*prices on atleast a 20min delay
Data provided by
© Australian Stock Report Pty Ltd. All rights reserved
